Plasma vitamin D level and change in albuminuria and eGFR according to sodium intake

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 12, 2015, Pages 2119-2127

  Keyzer, Charlotte A ^a   Lambers Heerspink, Hiddo J ^b   Joosten, Michel M ^a,d   Deetman, Petronella E ^a   Gansevoort, Ron T ^a   Navis, Gerjan ^a   Kema, Ido P ^c   de Zeeuw, Dick ^b   Bakker, Stephan J L ^a,d   de Borst, Martin H ^a  

^a Division of Nephrology   (Netherlands)

^b Zorggroep Noorderbreedte and De Tjongerschans   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; TRIACYLGLYCEROL; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; SODIUM INTAKE;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; POTASSIUM EXCRETION; PROSPECTIVE STUDY; SODIUM EXCRETION; SODIUM INTAKE; TANDEM MASS SPECTROMETRY; URINALYSIS; VITAMIN BLOOD LEVEL; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; BLOOD; CHI SQUARE DISTRIBUTION; COMPLICATION; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; URINE; VITAMIN D DEFICIENCY;

ADULT; AGED; ALBUMINURIA; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, LIQUID; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SODIUM, DIETARY; TANDEM MASS SPECTROMETRY; TIME FACTORS; URINALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84957805146     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03830415     Document Type: Article

References (46)

1. United States Renal Data System: 2014 Annual Data Report: An Overview of the Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014.
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic KidneyDisease-Mineral and BoneDisorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009.
3. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007.
4. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS: 25-hydroxyvitaminDlevels and albuminuria in the third national health and nutrition examination survey (NHANES III). Am J Kidney Dis 50: 69-77, 2007.
5. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75: 88-95, 2009.
6. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Sikaris KA, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR: Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis 62: 58-66, 2013.
7. de Borst MH, Vervloet MG, ter Wee PM, Navis G: Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 22: 1603-1609, 2011.
8. Weir MR, Dengel DR, Behrens MT, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25: 1339-1344, 1995.
9. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE; PREVEND Study Group:Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256: 324-330, 2004.
10. Krikken JA, Lely AT, Bakker SJ, Navis G: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 71: 260-265, 2007.
11. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98: 2621-2628, 1998.
12. Rebholz CM, Chen J, Zhao Q, Chen JC, Li J, Cao J, Gabriel Navar L, Lee Hamm L, Gu D, He J; GenSalt Collaborative Research Group: Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure. J Hypertens 33: 1394-1400, 2015.
13. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D: Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial. Lancet 376: 1543-1551, 2010.
14. De Nicola L, Conte G, Russo D, Gorini A, Minutolo R: Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: A prospective observational study. BMC Nephrol 13: 150, 2012.
15. Diercks GF, van Boven AJ, Hillege HL, Janssen WM, Kors JA, de Jong PE, Grobbee DE, Crijns HJ, van Gilst WH: Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 21: 1922-1927, 2000.
16. Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE; PREVEND Study Group. Prevention of Renal and Vascular End-stage Disease: Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med 38: 1107-1110, 2000.
17. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012.
18. Joosten MM, Gansevoort RT, Mukamal KJ, Lambers Heerspink HJ, Geleijnse JM, Feskens EJ, Navis G, Bakker SJ; PREVEND Study Group: Sodium excretion and risk of developing coronary heart disease. Circulation 129: 1121-1128, 2014.
19. Sachs MC, Shoben A, Levin GP, Robinson-Cohen C, Hoofnagle AN, Swords-Jenny N, Ix JH, Budoff M, Lutsey PL, Siscovick DS, Kestenbaum B, de Boer IH: Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: The Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 97: 1243-1251, 2013.
20. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, Calle EE, Flanders WD: Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: Insights fromsimulations basedonserum25-hydroxyvitamind. Am J Epidemiol 170: 88-94, 2009.
21. Forman JP, Scheven L, de Jong PE, Bakker SJ, Curhan GC, Gansevoort RT: Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125: 3108-3116, 2012.
22. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC: 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282: 29821-29830, 2007.
23. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238, 2002.
24. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D: Calciumindependent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 74: 170-179, 2008.
25. Zhang Y, Kong J, Deb DK, Chang A, Li YC: Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol 21: 966-973, 2010.
26. Qiao G, Kong J, Uskokovic M, Li YC: Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis. J Steroid Biochem Mol Biol 96: 59-66, 2005.
27. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000.
28. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin II and renal fibrosis. Hypertension 38: 635-638, 2001.
29. He W, Kang YS, Dai C, Liu Y: Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103, 2011.
30. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J: A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest 123: 4579-4594, 2013.
31. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A: Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 21: 889-897, 2006.
32. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S: The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 103: 558-562, 2007.
33. World Health Organization (WHO): Guideline: Sodium Intake for Adults and Children, Geneva, Switzerland, World Health Organization, 2012.
34. Rook M, Lely AT, Kramer AB, van Goor H, Navis G: Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage. Nephrol Dial Transplant 20: 59-64, 2005.
35. Samuel P, Ali Q, Sabuhi R, Wu Y, Hussain T: High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats. Am J Physiol Renal Physiol 303: F412-F419, 2012.
36. Boddi M, Poggesi L, Coppo M, Zarone N, Sacchi S, Tania C, Neri Serneri GG: Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension 31: 836-842, 1998.
37. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, Quigg RJ, Li YC: Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 73: 163-171, 2008.
38. Gonçalves JG, de Bragança AC, Canale D, Shimizu MH, Sanches TR, Moysés RM, Andrade L, Seguro AC, Volpini RA: Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury. PLoS One 9: e107228, 2014.
39. Zehnder D, Quinkler M, Eardley KS, Bland R, Lepenies J, Hughes SV, Raymond NT, Howie AJ, Cockwell P, Stewart PM, Hewison M: Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 74: 1343-1353, 2008.
40. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, Manning RD Jr.: Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 293: H3388-H3395, 2007.
41. Slagman MC, Nguyen TQ, Waanders F, Vogt L, Hemmelder MH, Laverman GD, Goldschmeding R, Navis G: Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy. Clin J Am Soc Nephrol 6: 1845-1850, 2011.
42. Guessous I, McClellan W, Kleinbaum D, Vaccarino V, Hugues H, Boulat O, Marques-Vidal P, Paccaud F, Theler JM, Gaspoz JM, Burnier M, Waeber G, Vollenweider P, Bochud M: Serum 25-hydroxyvitamin D level and kidney function decline in a swiss general adult population. Clin J Am Soc Nephrol 10: 1162-1169, 2015.
43. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P: 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 20: 2631-2639, 2009.
44. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005.
45. Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Kawachi H, Rakugi H, Imai E, Isaka Y: Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats. Nephrol Dial Transplant 24: 2354-2361, 2009.
46. Jones G: Extrarenal vitamin D activation and interactions between vitamin D₂, vitamin D₃, and vitamin D analogs. Annu Rev Nutr 33: 23-44, 2013.